Peter W. Hunt, MD

Peter Hunt
Global Health Sciences Faculty Affiliate

Phone: 415-476-4082 ext. 345
UCSF Box: 0874
Email: phunt@php.ucsf.edu
UCSF Profile

Project Sponsor
Location(s) Topics Start End
Mesalamine to Reduce T Cell Activation in HIV Infection California HIV/AIDS Research Program United States HIV/AIDS, Drug and Diagnostics Development
Immunologic Determinants of CD4+ T Cell Recovery in Treated HIV+ Africans Doris Duke Charitable Foundation Uganda HIV/AIDS
AIDS Clinical Trials Network (ACTG) -- Peter Hunt Task Order Social & Scientific Systems, Inc. United States HIV/AIDS
Novel approaches to monitoring and utilizing adherence to HIV therapy in Africa Massachusetts General Hospital Uganda HIV/AIDS
HIV Pathogenesis and Immunity in Viremic Non-Progressors University of California Irvine (UCI) United States HIV/AIDS
Innate Immune Response Genetics and T cell Activation in Treated HIV Infection NIH National Institute of Allergy and Infectious Disease Uganda HIV/AIDS
IDO-induced Tryptophan Catabolism and Mortality in Treated HIV-infected Africans NIH National Institute of Allergy and Infectious Disease Uganda HIV/AIDS
Inflammation, T Cell Senescence, and Mortality in Treated HIV Infection NIH National Institute of Allergy and Infectious Disease United States HIV/AIDS
The Determinants of T Cell Activation in HIV Infection NIH National Institute of Allergy and Infectious Disease United States HIV/AIDS
HIV-Specific T-Cell Responses in Rectal Mucosa University of California Davis United States Immunology
Intestinal MAIT Cells in HIV Infection University of California Davis United States HIV/AIDS
HIV-Specific T-cell Responses in Rectal Mucosa University of California Davis United States HIV/AIDS
Investigating Mechanisms of HIV Persistence in the Gut Northern California Institute for Research and Education, Inc. (NCIRE) United States HIV/AIDS, Immunology
Valganciclovir to Reduce T Cell Activation in HIV Infection Roche Laboratories United States HIV/AIDS, Drug and Diagnostics Development, Immunology
Immunologic determinants of age-related macular degeneration Mount Sinai School of Medicine, New York United States Eye Disease and Blindness, Immunology, Aging
AIDS Clinical Trials Network (ACTG)- Peter Hunt Task Order Brigham and Women's Hospital United States HIV/AIDS